Paola A. Lonati
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Novel mechanisms linking platelet activation to antiphospholipid syndrome.
Journal: Current opinion in immunology
Published: March 15, 2026
The Role of Anti-Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti-Phospholipid Antibody-Associated Preterm Delivery.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 02, 2026
Mechanisms sensitive to different drugs mediate a proadhesive and pro-thrombotic platelet phenotype in antiphospholipid syndrome.
Journal: Haematologica
Published: December 10, 2024
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy.
Journal: Biomedicines
Published: March 06, 2024
Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies.
Journal: International journal of molecular sciences
Published: December 29, 2023
Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study.
Journal: Thrombosis research
Published: November 15, 2022
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Journal: Autoimmunity reviews
Published: October 07, 2022
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers.
Journal: Frontiers in immunology
Published: April 27, 2022
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases.
Journal: Frontiers in pharmacology
Published: December 22, 2021
Last Updated: 09/26/2026